After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, MBRX falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Moleculin Biotech Inc is $18.97M. A total of 2.69 million shares were traded on the day, compared to an average of 5.22M shares.
In the most recent transaction, Foster Jonathan P. bought 270,270 shares of MBRX for 0.37 per share on Jun 23 ’25. After the transaction, the Chief Financial Officer now owns 287,587 company shares. In a previous transaction on Jun 23 ’25, KLEMP WALTER V bought 675,675 shares at 0.37 per share. MBRX shares that CEO and President owns now total 743,607.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, MBRX has a high of $3.65 and a low of $0.25.
As of this writing, MBRX has an earnings estimate of $0 per share for the current quarter. The company reported an EPS of -$1.7 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MBRX is Buy with a score of 5.00.
